Ascendis Pharma Endocrinology Division A/S

Denmark

Back to Profile

1-59 of 59 for Ascendis Pharma Endocrinology Division A/S Sort by
Query
Aggregations
IP Type
        Trademark 40
        Patent 19
Jurisdiction
        United States 27
        Europe 14
        World 12
        Canada 6
Date
2025 January 1
2025 (YTD) 1
2024 1
2023 5
2022 6
See more
IPC Class
A61K 38/27 - Growth hormone [GH], i.e. somatotropin 18
A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol 14
A61K 9/08 - Solutions 9
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof 8
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin 8
See more
NICE Class
09 - Scientific and electric apparatus and instruments 38
05 - Pharmaceutical, veterinary and sanitary products 33
10 - Medical apparatus and instruments 32
41 - Education, entertainment, sporting and cultural services 4
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 4
Status
Pending 13
Registered / In Force 46

1.

Novel Polymeric hGH Prodrugs

      
Application Number 18891744
Status Pending
Filing Date 2024-09-20
First Publication Date 2025-01-30
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Kurpiers, Thomas
  • Rau, Harald
  • Exner, Evelyn
  • Jensen, Steen
  • Rasmussen, Grethe Nørskov
  • Lessmann, Torben
  • Wegge, Thomas
  • Hermann, Alina
  • Schubert, Nina
  • Splanemann, Anna
  • Zettler, Joachim

Abstract

The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulations comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/08 - Solutions
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • C08G 65/334 - Polymers modified by chemical after-treatment with organic compounds containing sulfur

2.

Long-Acting Growth Hormone Treatment

      
Application Number 18674686
Status Pending
Filing Date 2024-05-24
First Publication Date 2024-11-07
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor
  • Sprogøe, Kennett
  • Egesborg, Henrik
  • Jensen, Steen
  • Kurpiers, Thomas

Abstract

The present invention relates a pharmaceutical formulation comprising a long-acting growth hormone for use in a method of treating growth hormone deficiency, wherein the long-acting growth hormone formulation is administered to a patient in a bracketed dosage regimen, to a multitude of unit dosage forms comprising a long-acting growth hormone formulation, wherein the unit dosage forms comprise increasing amounts of growth hormone equivalents and wherein the amount of growth hormone equivalents increases by at least 10% between one unit dosage form and the next higher dosage form; their use in a method of treating growth hormone deficiency and method of treating growth hormone deficiency in a bracketed dosing regimen.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61M 5/19 - Syringes having more than one chamber

3.

living HypoPara

      
Application Number 018888135
Status Registered
Filing Date 2023-06-14
Registration Date 2024-02-15
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Software and application software for use in the provision of medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders; Application software for mobile phones, application software for tablet computers, Application software for hand-held computers and personal computer application software, namely, Downloadable application software for sharing information related to hypoparathyroidism growth-related disorders, endocrinological disorders and bone disorders and the treatment of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders for use by patients with growth-related disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders. Education and instruction services; Arranging and conducting of conferences, symposiums, conferences, seminars, workshops, lectures and online education seminars and guides about pharmaceutical, medical and healthcare topics; Publication and reporting, electronic publication about pharmaceutical, medical and healthcare topics; Teaching, namely, Organisation of educational programmes for patients and healthcare providers in relation to hypoparathyroidism growth-related disorders, endocrinological disorders and bone disorders and the treatment of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders for use by patients with growth-related disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders. Provision and dissemination of information and Consultancy in relation to the following fields: Growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, Diagnosis and treatments, Medical screening, Medicine, Health and pharmaceutical products; Patient support programs, namely, the provision of health information to patients and healthcare providers in the areas of growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, including the provision of information on self-administration of medication; Provision of an online website with information related to hypoparathyroidism growth-related disorders, endocrinological disorders and bone disorders and treatment of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders for use by patients with growth-related disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders.

4.

know HypoPara

      
Application Number 018888168
Status Registered
Filing Date 2023-06-14
Registration Date 2023-10-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Software and application software for use in the provision of medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders; Application software for mobile phones, application software for tablet computers, Application software for hand-held computers and personal computer application software, namely A downloadable application software for sharing information related to hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders and the treatment of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders for use by patients with growth-related disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders. Education and instruction services; Arranging and conducting of conferences, symposiums, conferences, seminars, workshops, lectures and online education seminars and guides about pharmaceutical, medical and healthcare topics; Publication and reporting, electronic publication about pharmaceutical, medical and healthcare topics; Teaching, namely, Organisation of educational programs for patients and healthcare providers in relation to hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders and the treatment of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders for use by patients with growth-related disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders. Provision and dissemination of information and Consultancy in relation to the following fields: Growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, Diagnosis and treatments, Medical screening, Medicine, Health and pharmaceutical products; Patient support programs, namely, the provision of health information to patients and healthcare providers in the areas of growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, including the provision of information on self-administration of medication; Provision of an online website with information related to hypoparathyroidism growth-related disorders, endocrinological disorders and bone disorders and treatment of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders for use by patients with growth-related disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth-related disorders, endocrinological disorders and bone disorders.

5.

KNOW HYPOPARA

      
Serial Number 98041718
Status Pending
Filing Date 2023-06-14
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders Educational and teaching services, namely, providing conferences, symposiums, seminars, workshops, lectures, classes and online education seminars in the field of pharmaceuticals, medicine, and health care; Publication of non-downloadable electronic publications in the nature of advisory board reports, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Educational services, namely, conducting educational programs for patients and healthcare providers related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders Providing and sharing of medical information and advice relating to growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, medical screening, medicine, health and pharmaceutical products; Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

6.

LIVING HYPOPARA

      
Serial Number 98041740
Status Pending
Filing Date 2023-06-14
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders Educational and teaching services, namely, providing conferences, symposiums, seminars, workshops, lectures, classes and online education seminars in the field of pharmaceuticals, medicine, and health care; Publication of non-downloadable electronic publications in the nature of advisory board reports, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Educational services, namely, conducting educational programs for patients and healthcare providers related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders Providing and sharing of medical information and advice relating to growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, medical screening, medicine, health and pharmaceutical products; Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

7.

YORVIPAL

      
Serial Number 98006567
Status Pending
Filing Date 2023-05-22
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay information and estimates, providing access to secure medical documents, providing financial support services in the nature of payment processing; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

8.

UPYTHA

      
Application Number 1702814
Status Registered
Filing Date 2022-06-22
Registration Date 2022-06-22
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders. Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their authorization and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders. dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic. Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; software controlled drug delivery medical devices for medicine dosage and for providing web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; software controlled drug delivery medical devices for dosage management, and for use in medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patient remotely and at a clinic.

9.

PATHRYVA

      
Application Number 1697760
Status Registered
Filing Date 2022-06-22
Registration Date 2022-06-22
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders. Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their authorization and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders. dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic. Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; software controlled drug delivery medical devices for medicine dosage and for providing web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; software controlled drug delivery medical devices for dosage management, and for use in medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patient remotely and at a clinic.

10.

PATHRYVA

      
Application Number 222395300
Status Pending
Filing Date 2022-06-22
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders. (2) Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their authorization and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders. dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic. (3) Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; software controlled drug delivery medical devices for medicine dosage and for providing web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; software controlled drug delivery medical devices for dosage management, and for use in medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patient remotely and at a clinic.

11.

UPYTHA

      
Application Number 222950400
Status Pending
Filing Date 2022-06-22
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders. (2) Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medical treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their authorization and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders. dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic. (3) Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; software controlled drug delivery medical devices for medicine dosage and for providing web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; software controlled drug delivery medical devices for dosage management, and for use in medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patient remotely and at a clinic.

12.

GH CONNECT

      
Application Number 1659093
Status Registered
Filing Date 2022-02-15
Registration Date 2022-02-15
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for use in providing medical advice and advice on medical treatment, patient care and health insurance; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application o for sharing information about physical and mental disorders for use by patients and healthcare professionals; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application that coordinates the delivery of healthcare between healthcare providers, patients and the parties responsible for payment of healthcare, namely downloadable software, which allows individuals seeking medical education, information and services to locate a doctor and clinic for medical treatment in their geographical area, and allows physicians and healthcare professionals to communicate information about their authorization and area of expertise to patients and parties responsible for payment of health services; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application that enables healthcare providers to monitor patients, disseminate clinical information relevant to patient care, provide and exchange patient information and health services provided to patients; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for use in co-pay and other financial or medical access support; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for use in a communication platform that enables users to share health and healthcare information; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for measuring height, weight, blood pressure, serum calcium, blood sugar and heart rate; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for the use of delivery, exchange, retrieval and analysis of health and healthcare information; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for medical purposes, namely for formatting, displaying and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; downloadable application software for computers, mobile phones, tablets, handheld computers and PCs, namely a downloadable software application for providing healthcare related information, medication reminders and for tracking medical dosing history.

13.

LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN

      
Application Number 17310993
Status Pending
Filing Date 2020-03-03
First Publication Date 2022-03-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor Sprogøe, Kennett

Abstract

The present invention relates to a long-acting growth hormone or a pharmaceutical formulation comprising such long-acting growth hormone for use in a method of treating growth hormone deficiency with improved outcomes.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61P 5/06 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

14.

YORVIPATH

      
Serial Number 97197252
Status Registered
Filing Date 2021-12-30
Registration Date 2023-07-04
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers with integrated recorded software featuring web-based medical information collected via said apparatus for physical and psychological examination and assessment of patients remotely and at a clinic, sold as a unit; dosage management dispensers with integrated recorded software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic, namely, pen-type syringes and injection devices for administering drugs, sold as a unit

15.

PATHRYVA

      
Serial Number 97197222
Status Registered
Filing Date 2021-12-30
Registration Date 2024-01-23
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders

16.

UPYTHA

      
Serial Number 97197279
Status Registered
Filing Date 2021-12-30
Registration Date 2023-07-04
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers with integrated recorded software featuring web-based medical information collected via said apparatus for physical and psychological examination and assessment of patients remotely and at a clinic, sold as a unit; dosage management dispensers with integrated recorded software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic, namely, pen-type syringes and injection devices for administering drugs, sold as a unit

17.

PATHRYVA

      
Application Number 018628151
Status Registered
Filing Date 2021-12-23
Registration Date 2022-05-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; Pharmaceutical preparations for the treatment of disorders relating to growth, pharmaceutical preparations for the treatment of endocrinological disorders, pharmaceutical preparations for the treatment of skeletal disorders; Diagnostic preparations for medical use, namely, diagnostic preparations for the identification and detection of hypoparathyroidism, endocrinological disorders and skeletal disorders. Computer software and computer programs for use in providing medical advice and advice on medical treatment, patient care and health insurance within hypoparathyroidism, disorders relating to growth, endocrinological disorders and skeletal disorders; computer applicationsoftware, for use in relation to the following goods, Mobile telephones, Tablet computers, Palmtop computers, Personal computers, namely Downloadable application software for sharing information for use in the following fields: Disorders relating to hypoparathyroidism growth, endocrinological disorders and bone disorders and treatment of hypoparathyroidism, disorders relating to growth, endocrinological disorders and bone disorders for use by patients with disorders relating to growth, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, disorders relating to growth, endocrinological disorders and bone disorders; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, computer software that coordinates the delivery of health services between healthcare providers, patients and the parties responsible for payment of health services, namely computer software enabling individuals seeking medical education, information and service, to locate a doctor and medical clinic in their geographical area, and allows physicians and healthcare professionals to communicate information about the authorisation thereof and area of expertise to patients and parties responsible for payment of health services; computer applicationsoftware, for use in relation to the following goods, Mobile telephones, Tablet computers, Palmtop computers, Personal computers, namely Software that enables healthcare providers to monitor patients, disseminate clinical information relevant to patient care, deliver and exchange information about patients and healthcare services provided to patients; Downloadable software, software applications and mobile applications for co-pay and other financial or medical access support; Downloadable computer software for use as a communication platform that make it possible for the users to share information about health and healthcare; Downloadable software, software applications and mobile applications for measuring height, weight, blood pressure, serum calcium, blood sugar and pulse; Downloadable software, software applications and mobile applications for the delivery, exchange, retrieval and analysis of health and healthcare information; Formatting, displaying and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer applicationsoftware, for use in relation to the following goods, Mobile telephones, Tablet computers, Palmtop computers, Personal computers, Downloadable software application for delivery of healthcare-related information, medication reminders and for tracking medical dose history; The aforesaid relating to pharmaceutical preparations for the treatment of hypoparathyroidism, disorders relating to growth, endocrine-disrupting disorders, endocrinological disorders, and skeletal disorders. The aforesaid relating to pharmaceutical preparations for the treatment of hypoparathyroidism, disorders relating to growth, endocrine-disrupting disorders, endocrinological disorders, and skeletal disorders; Syringes for medical purposes and for injections; Syringes for injection of medical and surgical preparations, syringes in the shape of pens for surgical use; Digitally connected medical devices for monitoring dosage of pharmaceutical preparations for use in the treatment of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; Medical equipments, in particular, Infusion and injection devices for administering medicinal preparations; Devices and instruments for diagnostic purposes, namely dosing dispensers for medicines containing software for control of medical information in web-based physical and psychological examination and evaluation of patients remotely and in the clinic; Dosing dispensers containing software for control of medical information for control of medicines and for therapeutic use in web-based physical and psychological examination and evaluation of patients remotely and in the clinic.

18.

YORVIPATH

      
Application Number 018628152
Status Registered
Filing Date 2021-12-23
Registration Date 2022-05-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; Pharmaceutical preparations for the treatment of disorders relating to growth, pharmaceutical preparations for the treatment of endocrinological disorders, pharmaceutical preparations for the treatment of skeletal disorders; Diagnostic preparations for medical use, namely, diagnostic preparations for the identification and detection of hypoparathyroidism, endocrinological disorders and skeletal disorders. Computer software and computer programs for use in providing medical advice and advice on medical treatment, patient care and health insurance within hypoparathyroidism, disorders relating to growth, endocrinological disorders and skeletal disorders; computer applicationsoftware, in relation to the following goods, Mobile telephones, Tablet computers, Palmtop computers, Personal computers, namely, Downloadable application software for sharing information, for use in the following fields: Disorders relating to hypoparathyroidism growth, endocrinological disorders and bone disorders and treatment of hypoparathyroidism, disorders relating to growth, endocrinological disorders and bone disorders for use by patients with disorders relating to growth, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, disorders relating to growth, endocrinological disorders and bone disorders; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, computer software that coordinates the delivery of health services between healthcare providers, patients and the parties responsible for payment of health services, namely computer software enabling individuals seeking medical education, information and service, to locate a doctor and medical clinic in their geographical area, and allows physicians and healthcare professionals to communicate information about the authorisation thereof and area of expertise to patients and parties responsible for payment of health services; computer applicationsoftware for use in relation to the following goods: Mobile telephones, Tablet computers, Palmtop computers and Personal computers, namely Software that enables healthcare providers to monitor patients, disseminate clinical information relevant to patient care, deliver and exchange information about patients and healthcare services provided to patients; Downloadable software, software applications and mobile applications for co-pay and other financial or medical access support; Downloadable computer software for use as a communication platform that make it possible for the users to share information about health and healthcare; Downloadable software, software applications and mobile applications for measuring height, weight, blood pressure, serum calcium, blood sugar and pulse; Downloadable software, software applications and mobile applications for the delivery, exchange, retrieval and analysis of health and healthcare information; Formatting, displaying and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer applicationsoftware for use in relation to the following goods: Mobile telephones, Tablet computers, handheld computers and personal computers, Downloadable software application for delivery of healthcare-related information, medication reminders and for tracking medical dose history; The aforesaid relating to pharmaceutical preparations for the treatment of hypoparathyroidism, disorders relating to growth, endocrine-disrupting disorders, endocrinological disorders, and skeletal disorders. The aforesaid relating to pharmaceutical preparations for the treatment of hypoparathyroidism, disorders relating to growth, endocrine-disrupting disorders, endocrinological disorders, and skeletal disorders; Syringes for medical purposes and for injections; Syringes for injection of medical and surgical preparations, syringes in the shape of pens for surgical use; Digitally connected medical devices for monitoring dosage of pharmaceutical preparations for use in the treatment of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; Medical equipments, in particular, Infusion and injection devices for administering medicinal preparations; Devices and instruments for diagnostic purposes, namely dosing dispensers for medicines containing software for control of medical information in web-based physical and psychological examination and evaluation of patients remotely and in the clinic; Dosing dispensers containing software for control of medical information for control of medicines and for therapeutic use in web-based physical and psychological examination and evaluation of patients remotely and in the clinic.

19.

UPYTHA

      
Application Number 018628153
Status Registered
Filing Date 2021-12-23
Registration Date 2022-05-19
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; Pharmaceutical preparations for the treatment of disorders relating to growth, pharmaceutical preparations for the treatment of endocrinological disorders, pharmaceutical preparations for the treatment of skeletal disorders; Diagnostic preparations for medical use, namely, diagnostic preparations for the identification and detection of hypoparathyroidism, endocrinological disorders and skeletal disorders. Computer software and computer programs for use in providing medical advice and advice on medical treatment, patient care and health insurance within hypoparathyroidism, disorders relating to growth, endocrinological disorders and skeletal disorders; Computer application software formobile phones, Computer application software for tablet computers, Computer application software for handheld computers, Computer application software for personal computers, namely a downloadable application software for sharing information relating to disorders relating to hypoparathyroidism growth, endocrinological disorders and bone disorders and treatment of hypoparathyroidism, disorders relating to growth, endocrinological disorders and bone disorders for use by patients with disorders relating to growth, hypoparathyroidism and skeletal dysplasia in the medical; Field of hypoparathyroidism, disorders relating to growth, endocrinological disorders and bone disorders; Computer application software formobile phones, Computer application software for tablet computers, Computer application software for handheld computers, Computer application software for personal computer, namely Software that coordinates the providing of healthcare between healthcare providers, patients and the parties responsible for payment of healthcare, namely software that allows individuals seeking medical education, information and services to locate a physician and clinic for medical care in the geographic area thereof, and allows physicians and healthcare professionals to; Communicate information about their license and specialty area to patients and parties responsible for payment of healthcare; Computer application software formobile phones, Computer application software for tablet computers, Computer application software for personal computer and Computer application software for handheld computers, namely Software that enables healthcare providers to monitor patients, disseminate clinical information relevant to patient care, deliver and exchange information about patients and healthcare services provided to patients; Downloaded software, for use in the following fields: Co-pay and other financial or medical access support, Software applications and mobile applications for co-pay and other economical or medical access support; Downloadable computer software for use as a communication platform that make it possible for the users to share information about health and healthcare; Downloadable software, software applications and mobile applications for measuring height, weight, blood pressure, serum calcium, blood sugar and pulse; Downloaded software, for use in the following fields: Providing, exchange, retrieval and analysis of health and healthcare information, Software applications and mobile applications for delivery, sharing, collection and analysis of health and healthcare information; Formatting, displaying and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; Computer application software formobile phones, Computer application software for tablet computers, Computer application software for handheld computers, Computer application software for personal computer, Downloadable software application for delivery of healthcare-related information, medication reminders and for tracking medical dose history; The aforesaid relating to pharmaceutical preparations for the treatment of hypoparathyroidism, disorders relating to growth, endocrine-disrupting disorders, endocrinological disorders, and skeletal disorders. The aforesaid relating to pharmaceutical preparations for the treatment of hypoparathyroidism, disorders relating to growth, endocrine-disrupting disorders, endocrinological disorders, and skeletal disorders; Syringes for medical purposes and for injections; Syringes for injection of medical and surgical preparations, syringes in the shape of pens for surgical use; Digitally connected medical devices for monitoring dosage of pharmaceutical preparations for use in the treatment of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; Medical equipments, in particular Infusion and injection devices for administering medicinal preparations; Devices and instruments for diagnostic purposes, namely dosing dispensers for medicines containing software for control of medical information in web-based physical and psychological examination and evaluation of patients remotely and in the clinic; Dosing dispensers containing software for control of medical information for control of medicines and for therapeutic use in web-based physical and psychological examination and evaluation of patients remotely and in the clinic.

20.

GH CONNECT

      
Serial Number 90893403
Status Pending
Filing Date 2021-08-20
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for use in providing patient assistance; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to physical diseases for use by patients; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing a communications platform enabling users to share health and healthcare information; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored via injection pens and between said injection pens and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history

21.

PEGylated Recombinant Human Growth Hormone Compounds

      
Application Number 17215991
Status Pending
Filing Date 2021-03-29
First Publication Date 2021-07-22
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor
  • Rau, Harald
  • Kindermann, Susanne
  • Leßmann, Torben
  • Norskov Rasmussen, Grethe
  • Hersel, Ulrich
  • Wegge, Thomas
  • Sprogøe, Kennett

Abstract

A chemically modified human Growth Hormone (rhGH) prepared by attaching a transient linker which comprises a polyethylene glycol. The chemically modified protein may have a much longer lasting rhGH activity than that of the unmodified rhGH, enabling reduced dose and scheduling opportunities and the modified rhGH may not cause lipoatrophy. Also includes methods of use for the treatment and/or prevention of diseases or disorders in which use of growth hormone is beneficial.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • C07K 14/61 - Growth hormone [GH], i.e. somatotropin

22.

SKYTROFTO

      
Application Number 018510908
Status Registered
Filing Date 2021-07-08
Registration Date 2021-11-17
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use; by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health; care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for; use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

23.

SKYTROFZO

      
Application Number 018510911
Status Registered
Filing Date 2021-07-08
Registration Date 2021-11-17
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable oftware, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for; use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

24.

SKYTROFA

      
Application Number 1594787
Status Registered
Filing Date 2021-02-19
Registration Date 2021-02-19
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with treatment of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines, containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

25.

SKYTROFA

      
Application Number 211135900
Status Registered
Filing Date 2021-02-19
Registration Date 2024-02-12
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, enzyme replacement therapy for the treatment of lysosomal storage diseases, anti-inflammatory disease, pain, namely, for the relief of pain and for the treatment of chronic pain, respiratory system disorder, autoimmune disorders, vaccines for human and veterinary use , non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; diagnostic preparations for identification and proof of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, lysosomal storage diseases, anti-inflammatory disease, pain, respiratory system disorders, autoimmune disorders, non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases. (2) Medical devices for injection, dosage and control of pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, enzyme replacement therapy for the treatment of lysosomal storage diseases, anti-inflammatory disease, pain, namely, for the relief of pain and for the treatment of chronic pain, respiratory system disorder, autoimmune disorders, vaccines for human and veterinary use , non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with treatment of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical infusion and injection devices for administering drugs; apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines, containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

26.

Polymeric hGH prodrugs

      
Application Number 17006589
Grant Number 12133883
Status In Force
Filing Date 2020-08-28
First Publication Date 2020-12-17
Grant Date 2024-11-05
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor
  • Kurpiers, Thomas
  • Rau, Harald
  • Exner, Evelyn
  • Jensen, Steen
  • Rasmussen, Grethe Nørskov
  • Lessmann, Torben
  • Wegge, Thomas
  • Hermann, Alina
  • Schubert, Nina
  • Splanemann, Anna
  • Zettler, Joachim

Abstract

The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulation comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/08 - Solutions
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • C08G 65/334 - Polymers modified by chemical after-treatment with organic compounds containing sulfur

27.

QVOKLY

      
Application Number 1554688
Status Registered
Filing Date 2020-06-18
Registration Date 2020-06-18
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history'; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes namely dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; dosage management dispensers for medicines incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

28.

QVEQLI

      
Application Number 1554846
Status Registered
Filing Date 2020-06-18
Registration Date 2020-06-18
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes namely dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; dosage management dispensers for medicines incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

29.

LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN

      
Document Number 03131817
Status Pending
Filing Date 2020-03-03
Open to Public Date 2020-09-10
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor Sprogoe, Kennett

Abstract

The present invention relates to a long-acting growth hormone or a pharmaceutical formulation comprising such long-acting growth hormone for use in a method of treating growth hormone deficiency with improved outcomes.

IPC Classes  ?

  • A61K 9/08 - Solutions
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61P 5/06 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

30.

LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN

      
Application Number EP2020055513
Publication Number 2020/178273
Status In Force
Filing Date 2020-03-03
Publication Date 2020-09-10
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor Sprogøe, Kennett

Abstract

The present invention relates to a long-acting growth hormone or a pharmaceutical formulation comprising such long-acting growth hormone for use in a method of treating growth hormone deficiency with improved outcomes.

IPC Classes  ?

  • A61K 9/08 - Solutions
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61P 5/06 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

31.

SKYTROFA

      
Serial Number 90154281
Status Registered
Filing Date 2020-09-02
Registration Date 2021-08-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

32.

SKYTROFA

      
Application Number 018299971
Status Registered
Filing Date 2020-09-01
Registration Date 2021-02-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

33.

Dry growth hormone composition transiently linked to a polymer carrier

      
Application Number 16866764
Grant Number 12226457
Status In Force
Filing Date 2020-05-05
First Publication Date 2020-08-20
Grant Date 2025-02-18
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor
  • Rasmussen, Grethe Nørskov
  • Kindermann, Susanne
  • Rau, Harald
  • Wegge, Thomas

Abstract

The present invention relates to dry compositions of rhGH polymer prodrug containing a lyoprotectant and, optionally, one or more than one excipient. Such compositions are stable for at least 1 year, when stored at 2-8° C. The invention further relates to methods of manufacturing said compositions, containers comprising such composition as well as a kit of parts.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61M 5/19 - Syringes having more than one chamber

34.

QVEQLI

      
Serial Number 90008197
Status Registered
Filing Date 2020-06-18
Registration Date 2024-11-26
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

35.

QVOKLY

      
Serial Number 90008232
Status Registered
Filing Date 2020-06-18
Registration Date 2024-11-26
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

36.

QVOKLY

      
Application Number 018256672
Status Registered
Filing Date 2020-06-17
Registration Date 2020-10-28
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth-related disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; Diagnostic preparations for medical use, namely diagnostic preparations for the identification and detection of growth hormone deficiency, endocrine disorders, bone disorders, cancer and infectious diseases. Computer software and computer programs for use in the providing of medical advice and advice about medical treatment, patient care and health insurance in the field of disorders relating to growth, endocrine disorders, bone disorders, cancer and infectious diseases; Computer application software for mobile telephones, tablets, handheld and personal computers, namely a downloadable software application for sharing information relating to growth-related disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth-related disorders, endocrine disorders, bone disorders, cancer, infectious diseases for use on patients with growth-related disorders, hypoparathyroidism, skeletal dysplasia and diabetes in the medical field of growth-related disorders, endocrinological disorders, bone disorders, cancer and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, computer software that coordinates the delivery of health services between healthcare providers, patients and the parties responsible for payment of health services, namely computer software enabling individuals seeking medical education, information and service, to locate a doctor and medical clinic in their geographical area, and allows physicians and healthcare professionals to communicate information about the authorisation thereof and area of expertise to patients and parties responsible for payment of health services; Computer application software formobile phones, Tablet computers, handheld computers and personal computers, Namely software, That make it possible for healthcare providers to monitor patients, provide clinical information that is relevant for the care of the patient, deliver and share information about patients and healthcare services delivered to patients; Computer programs [downloadable software], Software applications and mobile applications for co-pay and other economical or medical access support; Downloadable computer software for use as a communication platform that make it possible for the users to share information about health and healthcare; Downloadable software, software applications and mobile applications for measuring height, weight, blood pressure, serum calcium, blood sugar and pulse; Computer programs [downloadable software], Software applications and mobile applications for delivery, sharing, collection and analysis of health and healthcare information; Formatting, displaying and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; Computer application software formobile phones, Tablet computers, handheld computers and personal computers, Downloadable software application for delivery of healthcare-related information, medication reminders and for tracking medical dose history; The aforesaid goods relating to pharmaceutical preparations for the treatment of disorders relating to growth, hormonal disorders, endocrine disorders, bone disorders, cancer and infectious diseases. Medical devices for the injection, dosage and control of drugs, in particular, medical devices for injection, dosage and control of drugs for the treatment of disorders relating to growth, hormonal disorders, endocrine disorders, bone disorders, cancer and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection of medical and surgical preparations, syringes in the shape of pens for surgical use; Digitally-connected medical devices for monitoring the dosage of pharmaceutical preparations for use in the treatment of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Devices and instruments for diagnostic purposes, namely dosing dispensers for medicines containing software for control of medical information in web-based physical and psychological examination and evaluation of patients remotely and in the clinic; Dosing dispensers containing software for control of medical information for control of medicines and for therapeutic use in web-based physical and psychological examination and evaluation of patients remotely and in the clinic.

37.

QVEQLI

      
Application Number 018256670
Status Registered
Filing Date 2020-06-17
Registration Date 2020-10-28
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of disorders relating to growth, pharmaceutical preparations for the treatment of endocrinological disorders, pharmaceutical preparations for the treatment of skeletal disorders, Pharmaceutical preparation for the treatment of cancer, Pharmaceutical preparations for the treatment of infectious diseases; Diagnostic preparations for medicinal use, Namely, Diagnostic preparations for identification and proof of the lack of growth hormone, endocrinology diseases, bone diseases and cancer and infectious diseases. Computer software and computer programs for use in the providing of medical advice and advice about medical treatment, patient care and health insurance in the field of disorders relating to growth, endocrine disorders, bone disorders, cancer and infectious diseases; Computer application software formobile phones, Tablet computers, handheld computers and personal computers, In particular, downloadable application software for sharing information relating to disorders relating to growth, endocrine disorders, bone disorders, cancer, infectious diseases and treatment of disorders relating to growth, endocrine disorders, bone disorders, cancer, infectious diseases for use in patients with disorders relating to growth, hypoparathyroidism, skeletal dysplasia and diabetes in the medical field of disorders relating to growth, endocrine disorders, bone disorders, cancer and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, computer software that coordinates the delivery of health services between healthcare providers, patients and the parties responsible for payment of health services, namely computer software enabling individuals seeking medical education, information and service, to locate a doctor and medical clinic in their geographical area, and allows physicians and healthcare professionals to communicate information about the authorisation thereof and area of expertise to patients and parties responsible for payment of health services; Computer application software formobile phones, Tablet computers, handheld computers and personal computers, Namely software, That make it possible for healthcare providers to monitor patients, provide clinical information that is relevant for the care of the patient, deliver and share information about patients and healthcare services delivered to patients; Computer programs [downloadable software], Software applications and mobile applications for co-pay and other economical or medical access support; Downloadable computer software for use as a communication platform that make it possible for the users to share information about health and healthcare; Downloadable software, software applications and mobile applications for measuring height, weight, blood pressure, serum calcium, blood sugar and pulse; Computer programs [downloadable software], Software applications and mobile applications for delivery, sharing, collection and analysis of health and healthcare information; Formatting, displaying and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; Computer application software formobile phones, Tablet computers, handheld computers and personal computers, Downloadable software application for delivery of healthcare-related information, medication reminders and for tracking medical dose history; The aforesaid goods relating to pharmaceutical preparations for the treatment of disorders relating to growth, hormonal disorders, endocrine disorders, bone disorders, cancer and infectious diseases. Medical devices for the injection, dosage and control of drugs, in particular, medical devices for injection, dosage and control of drugs for the treatment of disorders relating to growth, hormonal disorders, endocrine disorders, bone disorders, cancer and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection of medical and surgical preparations, syringes in the shape of pens for surgical use; Digitally-connected medical devices for monitoring the dosage of pharmaceutical preparations for use in the treatment of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Devices and instruments for diagnostic purposes, namely dosing dispensers for medicines containing software for control of medical information in web-based physical and psychological examination and evaluation of patients remotely and in the clinic; Dosing dispensers containing software for control of medical information for control of medicines and for therapeutic use in web-based physical and psychological examination and evaluation of patients remotely and in the clinic.

38.

GROVECKLY

      
Application Number 1523895
Status Registered
Filing Date 2019-09-20
Registration Date 2019-09-20
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes for use in dosage management for medicines, containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; medical apparatus for use in dosage management of medicines, incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

39.

QVEKLY

      
Application Number 1522059
Status Registered
Filing Date 2019-09-20
Registration Date 2019-09-20
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes for use in dosage management for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; medical apparatus for use in dosage management of medicines, incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

40.

SIMGHRO

      
Application Number 1522103
Status Registered
Filing Date 2019-09-20
Registration Date 2019-09-20
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes for use in dosage management for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; medical apparatus for use in dosage management of medicines incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

41.

RSETGHO

      
Application Number 018121583
Status Registered
Filing Date 2019-09-06
Registration Date 2020-01-30
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

42.

RSETGHO

      
Serial Number 88607066
Status Pending
Filing Date 2019-09-06
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

43.

PEGylated recombinant human growth hormone compounds

      
Application Number 16146253
Grant Number 10960053
Status In Force
Filing Date 2018-09-28
First Publication Date 2019-06-27
Grant Date 2021-03-30
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor
  • Rau, Harald
  • Kindermann, Susanne
  • Leßmann, Torben
  • Norskov Rasmussen, Grethe
  • Hersel, Ulrich
  • Wegge, Thomas
  • Sprogøe, Kennett

Abstract

A chemically modified human Growth Hormone (rhGH) prepared by attaching a transient linker which comprises a polyethylene glycol. The chemically modified protein may have a much longer lasting rhGH activity than that of the unmodified rhGH, enabling reduced dose and scheduling opportunities and the modified rhGH may not cause lipoatrophy. Also includes methods of use for the treatment and/or prevention of diseases or disorders in which use of growth hormone is beneficial.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • C07K 14/61 - Growth hormone [GH], i.e. somatotropin

44.

SIMGHRO

      
Application Number 018041792
Status Registered
Filing Date 2019-03-28
Registration Date 2019-09-26
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

45.

QVEKLY

      
Application Number 018041791
Status Registered
Filing Date 2019-03-28
Registration Date 2019-09-26
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

46.

GROVECKLY

      
Application Number 018041793
Status Registered
Filing Date 2019-03-28
Registration Date 2019-09-26
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases. Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable softwareapplication for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; Downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; Downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; Downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; Software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; Computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases. Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; Syringes for medical purposes and for injections; Syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

47.

QVEKLY

      
Serial Number 88360418
Status Registered
Filing Date 2019-03-28
Registration Date 2023-05-23
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

48.

SIMGHRO

      
Serial Number 88360434
Status Registered
Filing Date 2019-03-28
Registration Date 2023-07-04
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

49.

GROVECKLY

      
Serial Number 88360445
Status Registered
Filing Date 2019-03-28
Registration Date 2020-11-24
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

50.

Dry growth hormone composition transiently linked to a polymer carrier

      
Application Number 15901350
Grant Number 10682395
Status In Force
Filing Date 2018-02-21
First Publication Date 2018-07-05
Grant Date 2020-06-16
Owner Ascendis Pharma Endocrinology Division A/S (Denmark)
Inventor
  • Rasmussen, Grethe Nørskov
  • Kindermann, Susanne
  • Rau, Harald
  • Wegge, Thomas

Abstract

The present invention relates to dry compositions of rhGH polymer prodrug containing a lyoprotectant and, optionally, one or more than one excipient. Such compositions are stable for at least 1 year, when stored at 2-8° C. The invention further relates to methods of manufacturing said compositions, containers comprising such composition as well as a kit of parts.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61K 9/08 - Solutions
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61M 5/19 - Syringes having more than one chamber

51.

Polymeric hGH prodrugs

      
Application Number 15527744
Grant Number 10799563
Status In Force
Filing Date 2015-11-17
First Publication Date 2017-12-14
Grant Date 2020-10-13
Owner Ascendis Pharma Endocrinology Division (Denmark)
Inventor
  • Kurpiers, Thomas
  • Rau, Harald
  • Exner, Evelyn
  • Jensen, Steen
  • Rasmussen, Grethe Nørskov
  • Lessmann, Torben
  • Wegge, Thomas
  • Hermann, Alina
  • Schubert, Nina
  • Splanemann, Anna
  • Zettler, Joachim

Abstract

The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulations comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61K 9/08 - Solutions
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • C08G 65/334 - Polymers modified by chemical after-treatment with organic compounds containing sulfur

52.

Dry growth hormone composition transiently linked to a polymer carrier

      
Application Number 15340595
Grant Number 09919033
Status In Force
Filing Date 2016-11-01
First Publication Date 2017-03-02
Grant Date 2018-03-20
Owner
  • ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
  • ASCENDIS PHARMA A/S (Denmark)
Inventor
  • Rasmussen, Grethe Nørskov
  • Kindermann, Susanne
  • Rau, Harald
  • Wegge, Thomas

Abstract

The present invention relates to dry compositions of rhGH polymer prodrug containing a lyoprotectant and, optionally, one or more than one excipient. Such compositions are stable for at least 1 year, when stored at 2-8° C. The invention further relates to methods of manufacturing said compositions, containers comprising such composition as well as a kit of parts.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61M 5/19 - Syringes having more than one chamber
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

53.

PEGylated Recombinant Human Growth Hormone Compounds

      
Application Number 15000242
Grant Number 10098930
Status In Force
Filing Date 2016-01-19
First Publication Date 2016-07-21
Grant Date 2018-10-16
Owner
  • ASCENDIS PHARMA A/S (Denmark)
  • ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Rau, Harald
  • Kindermann, Susanne
  • Lebmann, Torben
  • Norskov Rasmussen, Grethe
  • Hersel, Ulrich
  • Wegge, Thomas
  • Sprogoe, Kennett

Abstract

A chemically modified human Growth Hormone (rhGH) prepared by attaching a transient linker which comprises a polyethylene glycol. The chemically modified protein may have a much longer lasting rhGH activity than that of the unmodified rhGH, enabling reduced dose and scheduling opportunities and the modified rhGH may not cause lipoatrophy. Also includes methods of use for the treatment and/or prevention of diseases or disorders in which use of growth hormone is beneficial.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • C07K 14/61 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

54.

POLYMERIC HGH PRODRUGS

      
Document Number 02968282
Status Pending
Filing Date 2015-11-17
Open to Public Date 2016-05-26
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Kurpiers, Thomas
  • Rau, Harald
  • Exner, Evelyn
  • Jensen, Steen
  • Rasmussen, Grethe Norskov
  • Lessmann, Torben
  • Wegge, Thomas
  • Hermann, Alina
  • Schubert, Nina
  • Splanemann, Anna
  • Zettler, Joachim

Abstract

The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulations comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

55.

NOVEL POLYMERIC HGH PRODRUGS

      
Application Number EP2015076813
Publication Number 2016/079114
Status In Force
Filing Date 2015-11-17
Publication Date 2016-05-26
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Kurpiers, Thomas
  • Rau, Harald
  • Exner, Evelyn
  • Jensen, Steen
  • Rasmussen, Grethe Nørskov
  • Lessmann, Torben
  • Wegge, Thomas
  • Hermann, Alina
  • Schubert, Nina
  • Splanemann, Anna
  • Zettler, Joachim

Abstract

The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulations comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.

IPC Classes  ?

  • A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups
  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin

56.

LONG-ACTING GROWTH HORMONE DOSAGE FORMS

      
Application Number EP2015077229
Publication Number 2016/079302
Status In Force
Filing Date 2015-11-20
Publication Date 2016-05-26
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Sprogøe, Kennett
  • Egesborg, Henrik
  • Jensen, Steen
  • Kurpiers, Thomas

Abstract

The present invention relates a pharmaceutical formulation comprising a long-acting growth hormone for use in a method of treating growth hormone deficiency, wherein the long-acting growth hormone formulation is administered to a patient in a bracketed dosage regimen, to a multitude of unit dosage forms comprising a long-acting growth hormone formulation, wherein the unit dosage forms comprise increasing amounts of growth hormone equivalents and wherein the amount of growth hormone equivalents increases by at least 10% between one unit dosage form and the next higher dosage form; their use in a method of treating growth hormone deficiency and method of treating growth hormone deficiency in a bracketed dosing regimen.

IPC Classes  ?

  • A61K 9/08 - Solutions
  • A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61P 5/02 - Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

57.

Dry growth hormone composition transiently linked to a polymer carrier

      
Application Number 13515621
Grant Number 09511122
Status In Force
Filing Date 2010-12-15
First Publication Date 2012-12-20
Grant Date 2016-12-06
Owner
  • ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
  • ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Rasmussen, Grethe Nørskov
  • Kindermann, Susanne
  • Rau, Harald
  • Wegge, Thomas

Abstract

The present invention relates to dry compositions of rhGH polymer prodrug containing a lyoprotectant and, optionally, one or more than one excipient. Such compositions are stable for at least 1 year, when stored at 2-8° C. The invention further relates to methods of manufacturing said compositions, containers comprising such composition as well as a kit of parts.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

58.

PEGylated recombinant human growth hormone compounds

      
Application Number 12990101
Grant Number 09272048
Status In Force
Filing Date 2009-04-29
First Publication Date 2011-05-12
Grant Date 2016-03-01
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Rau, Harald
  • Kinderman, Susanne
  • Lebmann, Torben
  • Rasmussen, Grethe Norskov
  • Hersel, Ulrich
  • Wegge, Thomas
  • Sprogoe, Kennett

Abstract

A chemically modified human Growth Hormone (rhGH) prepared by attaching a transient linker which comprises a polyethylene glycol. The chemically modified protein may have a much longer lasting rhGH activity than that of the unmodified rhGH, enabling reduced dose and scheduling opportunities and the modified rhGH may not cause lipoatrophy. Also includes methods of use for the treatment and/or prevention of diseases or disorders in which use of growth hormone is beneficial.

IPC Classes  ?

  • A61K 38/27 - Growth hormone [GH], i.e. somatotropin
  • C07K 14/61 - Growth hormone [GH], i.e. somatotropin
  • A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

59.

PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS

      
Document Number 03004716
Status In Force
Filing Date 2009-04-29
Open to Public Date 2009-11-05
Grant Date 2022-04-12
Owner ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Denmark)
Inventor
  • Rau, Harald
  • Kindermann, Susanne
  • Lessmann, Torben
  • Rasmussen, Grethe Norskov
  • Hersel, Ulrich
  • Wegge, Thomas
  • Sprogoe, Kennett

Abstract

A chemically modified human Growth Hormone (rhGH) prepared by attaching a transient linker which comprises a polyethylene glycol. The chemically modified protein may have a much longer lasting rhGH activity than that of the unmodified rhGH, enabling reduced dose and scheduling opportunities and the modified rhGH may not cause lipoatrophy. Also includes methods of use for the treatment and/or prevention of diseases or disorders in which use of growth hormone is beneficial.

IPC Classes  ?

  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
  • A61P 5/06 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
  • C07K 14/61 - Growth hormone [GH], i.e. somatotropin